InvestorsHub Logo
Followers 253
Posts 17906
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Thursday, 04/04/2024 11:03:22 PM

Thursday, April 04, 2024 11:03:22 PM

Post# of 423976
biopa, for some reason(relating to a “hidden identity”) I can’t respond directly to your most recent message. Suffice to say, I think if you trace my name and posts on the Amarin message board you will have my current assessment of where we shareholders and Amarin now stand. In short, I am more optimistic. I will have a better assessment after 1) the decision and opinion of the CAFC is released, and 2) Amarin’s posters and abstracts are presented this weekend, particularly Sunday’s poster that ACC says I need a meeting key to open and read. Maybe kiwi or exwannabe have a key and can open it to post the text. 3) I have not read the text and claims of the new patent to be granted by EU authorities either.

Meantime I suggest you read the article appearing at elaine.chen@statnews.com. Dew Diligence provides a link at post # 251995 on the Biotech Value board. Ask yourself: Does this article relate in any way to the Phase 3 BRAVE clinical trial that is examining the effect of Vascepa as a biomarkers diagnostic of dementia and AD?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News